Single Gene Sequencing tests in Dubai & UAE

Compare available Single Gene Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

297

Listed price range

2,800.00–4,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene Sequencing test prices

Showing 241–255 of 297 matching tests.

Single Gene Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2575 SLC25A19 Gene Sequencing (Amish Microcephaly Type) Test This test evaluates the SLC25A19 gene for pathogenic variants associated with Amish microcephaly.	Peripheral Whole Blood or FTA Dried Blood Spot Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC25A19 gene", "Copy Number Variations (CNV) in the SLC25A19 gene"] Parameters [] Preparation [] Indications ["Neonates with unexplained profound microcephaly", "Differential diagnosis of severe neurological disorders", "Identification of pathogenic variants in SLC25A19"] Measurement technique Confirm with laboratory Codes LOINC: 58217-2 ICD-10: Q02, E75.5 Clinical summary This test evaluates the SLC25A19 gene for pathogenic variants associated with Amish microcephaly.
TEST-5532 SLC25A4 Gene: Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 2, Autosomal Dominant Test This genetic test analyzes the SLC25A4 gene to detect mutations associated with autosomal dominant progressive external ophthalmoplegia with mitochondrial deletions type 2.	Whole Blood (EDTA) or FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SLC25A4 gene sequence", "Single nucleotide variants", "Small insertions/deletions", "Copy number changes"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any mitochondrial support supplements or antiepileptics"] Indications ["Suspected diagnosis of progressive external ophthalmoplegia with mitochondrial deletions type 2", "Family history of the disorder", "Genetic counselling for at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 82939-2 ICD-10: G71.3, H49.819, Z14.8 Clinical summary This genetic test analyzes the SLC25A4 gene to detect mutations associated with autosomal dominant progressive external ophthalmoplegia with mitochondrial deletions type 2.
TEST-3539 SLC26A1 Gene Genetic Test This test identifies pathogenic variants in the SLC26A1 gene, which are associated with an increased risk of developing calcium oxalate kidney stones due to impaired oxalate handli...	Whole Blood (EDTA) or Buccal DNA Swab	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SLC26A1 gene pathogenic variants", "Copy Number Variants (CNVs) in SLC26A1"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed prior to testing"] Indications ["Patients with recurrent calcium oxalate nephrolithiasis", "Individuals with a positive family history of nephrolithiasis", "Elective genetic risk assessment in stable patients"] Measurement technique Confirm with laboratory Codes LOINC: 82305-9 ICD-10: N20.0 Clinical summary This test identifies pathogenic variants in the SLC26A1 gene, which are associated with an increased risk of developing calcium oxalate kidney stones due to impaired oxalate handling.
TEST-6167 SLC30A10 Gene Analysis (Hypermanganesemia with Dystonia, Polycythemia & Cirrhosis) Test This test identifies genetic mutations in the SLC30A10 gene associated with hypermanganesemia, dystonia, polycythemia, and cirrhosis.	Whole blood (EDTA), extracted DNA, or FTA card	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC30A10 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions"] Indications ["Suspected hypermanganesemia with dystonia, polycythemia, and cirrhosis", "Family history of related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 82940-5 ICD-10: E83.89 Clinical summary This test identifies genetic mutations in the SLC30A10 gene associated with hypermanganesemia, dystonia, polycythemia, and cirrhosis.
TEST-5031 SLC34A3 Gene Hypophosphatemic Rickets with Hypercalciuria Genetic Test This genetic test analyzes the SLC34A3 gene to diagnose hereditary hypophosphatemic rickets with hypercalciuria (HHRH).	Whole Blood (EDTA), Extracted DNA (>500 ng), or FTA Card Blood Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SLC34A3 gene sequence", "Pathogenic variants in SLC34A3"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected HHRH based on biochemical findings", "Family history of HHRH", "Distinguishing HHRH from other phosphate-wasting disorders"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: E83.31, N25.89 Clinical summary This genetic test analyzes the SLC34A3 gene to diagnose hereditary hypophosphatemic rickets with hypercalciuria (HHRH).
TEST-3494 SLC45A2 Gene Sequencing for Oculocutaneous Albinism Type 4 (OCA4) Test This test detects pathogenic variants in the SLC45A2 gene associated with Oculocutaneous Albinism Type 4 (OCA4).	Peripheral Whole Blood (EDTA Tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC45A2 gene", "Copy Number Variations (CNV) in the SLC45A2 gene"] Parameters [] Preparation [] Indications ["Individuals with clinical features suggestive of OCA4", "Family members of known OCA4 patients seeking carrier status", "Prenatal testing (with genetic counseling)"] Measurement technique Confirm with laboratory Codes LOINC: 94231-1 ICD-10: E70.319 Clinical summary This test detects pathogenic variants in the SLC45A2 gene associated with Oculocutaneous Albinism Type 4 (OCA4).
TEST-5620 SLC52A3 Gene (Fazio-Londe Disease) Genetic Test This test evaluates the SLC52A3 gene for pathogenic variants associated with Fazio-Londe disease, a rare genetic disorder affecting riboflavin transport.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC52A3 gene", "Riboflavin transporter RFVT3 function"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected Fazio-Londe disease", "Childhood-onset progressive bulbar palsy", "Family history of Fazio-Londe disease", "Differential diagnosis of neurological disorders"] Measurement technique Confirm with laboratory Codes LOINC: 94122-6 ICD-10: G12.2 Clinical summary This test evaluates the SLC52A3 gene for pathogenic variants associated with Fazio-Londe disease, a rare genetic disorder affecting riboflavin transport.
TEST-2517 SMARCA2 Gene Nicolaides-Baraitser Syndrome Genetic Test This test identifies pathogenic variants in the SMARCA2 gene associated with Nicolaides-Baraitser syndrome.	Peripheral Whole Blood (EDTA) or Extracted Genomic DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SMARCA2 gene coding regions", "SMARCA2 gene conserved splice sites"] Parameters [] Preparation ["No special preparation such as fasting is required", "Ensure child is well-hydrated"] Indications ["Suspected Nicolaides-Baraitser syndrome based on clinical features", "Family counseling for NCBRS"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.1 Clinical summary This test identifies pathogenic variants in the SMARCA2 gene associated with Nicolaides-Baraitser syndrome.
TEST-5569 SMPX Gene (Deafness, X-Linked Type 4) Genetic Test This test detects pathogenic variants in the SMPX gene associated with X-linked type 4 non-syndromic hearing loss.	Whole blood, Extracted DNA, or FTA Card	21–28 working days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SMPX gene coding region", "SMPX gene splice sites"] Parameters [] Preparation [] Indications ["Diagnosis of X-linked type 4 deafness", "Carrier screening for at-risk family members", "Assessment for cochlear implant candidacy"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: H90.3 Clinical summary This test detects pathogenic variants in the SMPX gene associated with X-linked type 4 non-syndromic hearing loss.
TEST-2982 SNAP29 Gene CEDNIK Syndrome Genetic Test This test evaluates the SNAP29 gene for pathogenic variants associated with CEDNIK syndrome.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SNAP29 gene", "Copy number changes in the SNAP29 gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any anticoagulant therapy or bleeding disorders"] Indications ["Individuals with clinical features suggestive of CEDNIK syndrome", "Family members of individuals diagnosed with CEDNIK syndrome for carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 91719-8 ICD-10: Q87.8 Clinical summary This test evaluates the SNAP29 gene for pathogenic variants associated with CEDNIK syndrome.
TEST-2930 SOST Gene Craniodiaphyseal Dysplasia Genetic Test This test detects pathogenic variants in the SOST gene associated with autosomal dominant craniodiaphyseal dysplasia.	Peripheral whole blood (3-5 mL EDTA) or FTA dried blood spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SOST gene pathogenic variants", "Autosomal dominant craniodiaphyseal dysplasia"] Parameters [] Preparation ["No specific dietary or medication modifications required", "Inform phlebotomist of anticoagulant therapy or bleeding disorders"] Indications ["Clinical features suggestive of craniodiaphyseal dysplasia", "First-degree relatives of a confirmed case"] Measurement technique Confirm with laboratory Codes LOINC: 60512-8 ICD-10: Q78.8 Clinical summary This test detects pathogenic variants in the SOST gene associated with autosomal dominant craniodiaphyseal dysplasia.
TEST-4484 SOST Gene Van Buchem Disease Genetic Test This test evaluates the SOST gene for pathogenic variants associated with Van Buchem disease (sclerosteosis). It identifies single-nucleotide variants, insertions, deletions, and c...	Peripheral Whole Blood (EDTA) or FTA Card Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SOST gene variants", "Single-nucleotide variations", "Insertions/Deletions (Indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No fasting required", "No special dietary restrictions", "Mandatory pre-test genetic counselling with a three-generation pedigree chart"] Indications ["Diagnosis of Van Buchem disease (sclerosteosis)", "Differentiation from other sclerosing bone dysplasias", "Genetic counseling for individuals with suspected or confirmed Van Buchem disease", "Pre-test genetic counseling required"] Measurement technique Confirm with laboratory Codes LOINC: 83443-3 ICD-10: Q78.8 Clinical summary This test evaluates the SOST gene for pathogenic variants associated with Van Buchem disease (sclerosteosis). It identifies single-nucleotide variants, insertions, deletions, and copy number variations.
TEST-4356 SPATA5 Gene Epilepsy, Hearing Loss, and Mental Retardation Syndrome Genetic Test This genetic test evaluates the SPATA5 gene for mutations associated with epilepsy, hearing loss, and intellectual disability.	Peripheral whole blood (EDTA), extracted genomic DNA, or dried blood spot (FTA card)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SPATA5 gene sequence", "Pathogenic variants in SPATA5"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any anticoagulant medication"] Indications ["Suspected SPATA5-related disorder", "Family history of SPATA5-related disorder", "Unexplained epilepsy, hearing loss, and intellectual disability"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q87.8, G40.9, H90.3, F70 Clinical summary This genetic test evaluates the SPATA5 gene for mutations associated with epilepsy, hearing loss, and intellectual disability.
TEST-4006 SPEG Gene Centronuclear Myopathy Type 5 Genetic Test This test evaluates the SPEG gene for pathogenic variants associated with centronuclear myopathy type 5.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPEG gene", "Single nucleotide variants (SNVs)", "Insertions and deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation [] Indications ["Clinical suspicion of congenital myopathy with central nuclei", "Definitive diagnosis", "Prognosis", "Informed family planning"] Measurement technique Confirm with laboratory Codes LOINC: 81260-0 ICD-10: G71.2 Clinical summary This test evaluates the SPEG gene for pathogenic variants associated with centronuclear myopathy type 5.
TEST-5625 SPG11 Gene Sequencing (NGS) Test This test analyzes the SPG11 gene for mutations associated with Hereditary Spastic Paraplegia Type 11 (HSP-11).	Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card)	10–14 business days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPG11 gene", "Coding regions of the SPG11 gene"] Parameters [] Preparation [] Indications ["Suspected Hereditary Spastic Paraplegia Type 11 (HSP-11)", "Progressive lower limb spasticity and weakness", "Family history of HSP-11"] Measurement technique Confirm with laboratory Codes LOINC: 40825-5 ICD-10: G11.4 Clinical summary This test analyzes the SPG11 gene for mutations associated with Hereditary Spastic Paraplegia Type 11 (HSP-11).

Category overview

Single Gene Sequencing: overview

Achieving a definitive diagnosis for a monogenic disorder often requires reading the entire genetic code of a specific gene to find elusive errors. As an elite subspecialty within our Genetics department, Single Gene Sequencing expansively scans the entirety of a single targeted gene to uncover rare or novel mutations. Utilizing state-of-the-art diagnostic technology, this comprehensive molecular screening provides the critical clarity needed to establish a firm diagnosis, safely guiding customized medical management and targeted therapeutic interventions. Consistently ranked among the top diagnostic labs in the UAE, DNA Labs guarantees the utmost in patient confidentiality, uncompromising analytical accuracy, and prompt, reliable reporting. Find the clear, definitive answers you need—schedule your single gene sequencing testing in UAE, arrange a comfortable home sample collection, or contact our specialized medical genetics professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.